Uk Pet Nutraceuticals Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

The UK pet nutraceuticals market encompasses products such as dietary supplements, functional treats, and fortified pet foods that deliver health benefits beyond basic nutrition. With a 2026 valuation of approximately £295 million, the sector represents a meaningful slice of the UK's overall £9 billion pet care industry and accounts for roughly 22% of the European pet nutraceuticals market.

A key catalyst is the humanisation of pets, whereby owners increasingly view companion animals as family members and are willing to spend more on their health and wellbeing. Rising pet adoption rates post-pandemic, combined with greater veterinary awareness of nutritional interventions, have expanded the addressable market. Additionally, an aging pet population creates sustained demand for joint support, cognitive health, and senior wellness products.

The market is typically segmented by animal type, dogs represent the largest segment given their higher population and spending levels, followed by cats, and by product type, including hip and joint supplements, skin and coat formulas, digestive aids, calming products, and multivitamins. Distribution is split across veterinary clinics, pet specialty stores, supermarkets, and online channels.

What are the recent trends and outlook?

Looking ahead, the market is expected to maintain solid single-digit to low-double-digit growth through the early 2030s. Key trends include demand for clean-label, sustainably sourced, and plant-based ingredients, as well as personalised nutrition informed by genetic testing. Regulatory clarity around product claims and veterinary involvement in recommendations is likely to shape the competitive dynamics.